Cargando…

Associations between body circumference and testosterone levels and risk of metabolic dysfunction-associated fatty liver disease: a mendelian randomization study

BACKGROUD: Body circumference and testosterone levels have been reported as associated with metabolic dysfunction-associated fatty liver disease (MAFLD) risk. However, whether body circumference and testosterone levels play a role in the development of MAFLD remains inconclusive. METHODS: Using a la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Lin, Sun, Jianguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061974/ https://www.ncbi.nlm.nih.gov/pubmed/36997893 http://dx.doi.org/10.1186/s12889-023-15467-4

Ejemplares similares

Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study
por: Zhao, Jian, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023)

Mendelian randomization suggests that head circumference, but not birth weight and length, associates with intelligence
por: Qian, Li, et al.
Publicado: (2021)

Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Onishi, Saori, et al.
Publicado: (2023)

Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women
por: Fatani, Sameer H, et al.
Publicado: (2018)

Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study
por: Yuan, Shuai, et al.
Publicado: (2022)

Association between testosterone and cancers risk in women: a two-sample Mendelian randomization study
por: Li, Zhizhou, et al.
Publicado: (2023)

Bioavailable testosterone level is associated with COVID-19 severity in female: A sex-stratified Mendelian randomization study
por: Liu, Luna, et al.
Publicado: (2022)

Testosterone in Female Depression: A Meta-Analysis and Mendelian Randomization Study
por: Maharjan, Dhruba Tara, et al.
Publicado: (2021)

A Mendelian randomization study of testosterone and cognition in men
por: Zhao, Jie V., et al.
Publicado: (2016)

The Potential Effect of Aberrant Testosterone Levels on Common Diseases: A Mendelian Randomization Study
por: Syed, Ali Alamdar Shah, et al.
Publicado: (2020)

Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study
por: Zhang, Weiwei, et al.
Publicado: (2017)

Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment
por: Yu, Qiang, et al.
Publicado: (2022)

A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease
por: Kim, Sunmi, et al.
Publicado: (2012)

Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men
por: Maseroli, E., et al.
Publicado: (2020)

Association between omega-3/6 fatty acids and cholelithiasis: A mendelian randomization study
por: Sun, Qi, et al.
Publicado: (2022)

Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation()
por: Schooling, C. Mary, et al.
Publicado: (2018)

Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women
por: Klisic, Aleksandra, et al.
Publicado: (2017)

Mid‐upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic‐associated fatty liver disease: A population based observational study
por: Wang, Xiaoxiao, et al.
Publicado: (2022)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Low-Carbohydrate and Low-Fat Diet with Metabolic-Dysfunction-Associated Fatty Liver Disease
por: Hu, Chengxiang, et al.
Publicado: (2023)

Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Therapeutic developments in metabolic dysfunction-associated fatty liver disease
por: Shi, Yiwen, et al.
Publicado: (2022)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Investigating the Association Between Seven Sleep Traits and Nonalcoholic Fatty Liver Disease: Observational and Mendelian Randomization Study
por: Fan, Hong, et al.
Publicado: (2022)

Association Between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study
por: Li, Hong, et al.
Publicado: (2023)

The Fatty Liver Index, the Strongest Risk Factor for Low Testosterone Level
por: Liu, Luna, et al.
Publicado: (2023)

Associations between neck circumference and markers of dysglycemia, non-alcoholic fatty liver disease, and dysmetabolism independent of Body Mass Index in an Emirati population
por: Fojas, Esphie Grace Fodra, et al.
Publicado: (2022)

Investigating the association of testosterone with survival in men and women using a Mendelian randomization study in the UK Biobank
por: Schooling, C. M., et al.
Publicado: (2021)

The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
por: Martín-Mateos, Rosa, et al.
Publicado: (2021)

Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
por: Mohammadi-Shemirani, Pedrum, et al.
Publicado: (2020)

Investigating the association between body fat and depression via Mendelian randomization
por: Speed, Maria S., et al.
Publicado: (2019)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Neck Circumference Predicts the Occurrence and Remission of Metabolic Associated Fatty Liver Disease: A Longitudinal Study of Community-Dwelling Population
por: Cao, Weijie, et al.
Publicado: (2022)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease
por: Machado, Mariana Verdelho
Publicado: (2021)

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
por: Wang, Xiaolin, et al.
Publicado: (2022)

Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Hwang, Tae-In, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d10chjuolod0frumdjfqa2966a